![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/bayer-hua-medicine-snag-first-class-nod-china-roche-castoff-diabetes-drug
https://www.scoop.co.nz/stories/GE2109/S00183/researchers-present-key-research-results-on-diabetes-remission-of-dorzagliatin.htm
https://www.asiaone.com/business/hua-and-sinopharm-announced-supply-chain-strategic-cooperation
https://www.biospectrumasia.com/news/25/16551/hua-medicine-bayer-bring-novel-diabetes-treatment-in-china.html
https://www.acnnewswire.com/press-release/english/59982/hua-medicine-announces-positive-24-week-topline-results-of-phase-iii-metformin-combination-trial-of-dorzagliatin
https://endpts.com/two-years-in-hong-kongs-biotech-experiment-has-been-validated/
https://www.globenewswire.com/news-release/2020/04/27/2022101/0/en/Hua-Medicine-Announces-Positive-Results-of-the-Combination-Study-of-Dorzagliatin-with-Empagliflozin-a-SGLT-2-inhibitor.html
https://www.biospectrumasia.com/news/26/15446/hua-medicine-appoints-former-u-s-fda-officer-as-cto.html
https://endpts.com/arch-backed-chinese-biotech-scores-phiii-win-for-glucokinase-modulating-diabetes-drug/
https://endpts.com/nine-listings-and-3-8b-later-hkex-celebrates-one-year-biotech-anniversary-with-cro-debut/